Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 49 points (0.3%) at 16,147 as of Friday, Nov. 29, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,869 issues advancing vs. 987 declining with 109 unchanged. The Diversified Services industry currently sits up 0.4% versus the S&P 500, which is up 0.3%. A company within the industry that fell today was Net 1 Ueps Technologies ( UEPS), up 29.0%. Top gainers within the industry include KBR ( KBR), up 1.8%, R.R. Donnelley & Sons Company ( RRD), up 1.6% and Priceline.com ( PCLN), up 0.7%. TheStreet would like to highlight 5 stocks pushing the industry lower today: 5. Qiagen ( QGEN) is one of the companies pushing the Diversified Services industry lower today. As of noon trading, Qiagen is down $0.20 (-0.8%) to $23.40 on light volume. Thus far, 135,380 shares of Qiagen exchanged hands as compared to its average daily volume of 731,000 shares. The stock has ranged in price between $23.39-$23.59 after having opened the day at $23.48 as compared to the previous trading day's close of $23.60. QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. Qiagen has a market cap of $5.5 billion and is part of the services sector. The company has a P/E ratio of 43.7, above the S&P 500 P/E ratio of 17.7. Shares are up 30.0% year to date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Qiagen a buy, no analysts rate it a sell, and 11 rate it a hold. TheStreet Ratings rates Qiagen as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Qiagen Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.